Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 05-2018 | 02-2018 | 11-2017 | 08-2017 | 05-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,466 | -798 | -476 | -207 | -909 |
| Depreciation Amortization | 187 | 140 | 94 | 49 | 219 |
| Income taxes - deferred | 31 | N/A | N/A | N/A | N/A |
| Accounts receivable | 253 | -102 | -3 | 5 | -132 |
| Other Working Capital | 40 | -209 | 6 | 22 | -81 |
| Other Operating Activity | -219 | 117 | 14 | 7 | 179 |
| Operating Cash Flow | $-1,174 | $-852 | $-363 | $-125 | $-723 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -130 | -74 | -53 | -20 | -96 |
| Investing Cash Flow | $-130 | $-74 | $-53 | $-20 | $-96 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,294 | 304 | 14 | 1 | 158 |
| Financing Cash Flow | $1,294 | $304 | $14 | $1 | $158 |
| Exchange Rate Effect | -10 | -6 | -5 | -1 | -2 |
| Beginning Cash Position | 1,226 | 1,226 | 1,226 | 1,226 | 1,889 |
| End Cash Position | 1,205 | 597 | 818 | 1,081 | 1,226 |
| Net Cash Flow | $-21 | $-628 | $-408 | $-145 | $-664 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,174 | -852 | -363 | -125 | -723 |
| Capital Expenditure | -130 | -74 | -53 | -20 | -96 |
| Free Cash Flow | -1,305 | -927 | -416 | -145 | -819 |